BCAS1 antibody (AA 532-550)
Quick Overview for BCAS1 antibody (AA 532-550) (ABIN1732242)
Target
See all BCAS1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 532-550
-
Specificity
- Reacts with human BCAS1.
-
Purification
- Purified
-
Immunogen
- Synthetic peptide corresponding to amino acids 532-550 of human BCAS1/NABC1.
-
Isotype
- IgG
-
-
-
-
Application Notes
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only:
WB(1 - 5 μg/mL) -
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS, pH 7.4
-
Handling Advice
- Dilute in PBS or medium that is identical to that used in the assay system.
-
Storage
- -20 °C
-
Storage Comment
- Stable for at least one year at -20°C. Avoid multiple freeze-thaw cycles.
-
Expiry Date
- 12 months
-
-
- BCAS1 (Breast Carcinoma Amplified Sequence 1 (BCAS1))
-
Alternative Name
- BCAS1 / NABC1
-
Background
-
Breast Carcinoma Amplified Sequence 1 (BCAS1), also known as Novel Amplified in Breast Cancer 1 (NABC1) was isolated from a region at 20q13 and is amplified in several tumor types. It is associated with more aggressive tumor phenotypes. BCAS1/NABC1 is highly expressed in some, but not all, breast cancer cell lines and in some breast tumors at 20q13.2. The BCAS1/NABC1 gene is predicted to encode a protein of 584 amino acids with no significant homology to other proteins.
Breast carcinoma-amplified sequence 1 Amplified and overexpressed in breast cancer Novel amplified in breast cancer 1 Gene name: BCAS1, AIBC1, NABC1 -
Gene ID
- 8537
-
UniProt
- O75363
Target
-